Supporting these findings, DNMT3A mutations are frequently observed in adult patients with de novo Acute Myeloid Leukemia (AML) [25,26,27,28], but they are rarely seen in pediatric AML [29]. This evidence concerns the gene DNMT3A and acute myeloid leukemia.